Suchergebnisse - "Vallet, Sonia"

PubPharm (135)

101

Fatty acid synthase is a novel therapeutic target in multiple myeloma

enthalten in: British journal of haematology | 2008

von Okawa, Y. | Hideshima, T. | Ikeda, H. | +11

RetractionIn: Cotter F. Br J Haematol. 2008 May;141(5):659. - PMID 20712068

102

p38 mitogen-activated protein kinase inhibitor LY2228820 enhances bortezomib-induced cytotoxicity and inhibits osteoclastogenesis in multiple myeloma; therapeutic implications

enthalten in: British journal of haematology | 2008

von Ishitsuka, K. | Hideshima, T. | Neri, P. | +16

103

Clinical, radiographic, and biochemical characterization of multiple myeloma patients with osteonecrosis of the jaw

enthalten in: Clinical cancer research : an official journal of the American Association for Cancer Research | 2008

von Raje, N. | Woo, S. | Hande, K. | +17

CommentIn: Clin Cancer Res. 2008 Dec 15;14(24):8321; author reply 8321-2. - PMID 19088052

104

High dose of Zoledronic acid inhibits both osteoclasts and osteoblasts in an In Vivo mouse model

enthalten in: Bone | 2008

von Pozzi, S. | Hideshima, T. | Vallet, S. | +17

105

Pharmacologic targeting of a stem/progenitor population in vivo is associated with enhanced bone regeneration in mice

enthalten in: The Journal of clinical investigation | 2008

von Mukherjee, S. | Raje, N. | Schoonmaker, J. | +18

CommentIn: J Clin Invest. 2008 Feb;118(2):462-4. - PMID 18219395

106

Targeting Akt and heat shock protein 90 produces synergistic multiple myeloma cell cytotoxicity in the bone marrow microenvironment

enthalten in: Clinical cancer research : an official journal of the American Association for Cancer Research | 2008

von Huston, A. | Leleu, X. | Jia, X. | +16

ErratumIn: Clin Cancer Res. 2024 Feb 16;30(4):922. - PMID 38362725

107

Targeting Akt and Heat Shock Protein 90 Produces Synergistic Multiple Myeloma Cell Cytotoxicity in the Bone Marrow Microenvironment

enthalten in: Clinical cancer research | 2008

von Huston, A. | Leleu, X. | Jia, X. | +16

108

High dose of Zoledronic acid inhibits both osteoclasts and osteoblasts in an In Vivo mouse model

enthalten in: Bone | 2008

von Pozzi, S. | Hideshima, T. | Vallet, S. | +16

109

Clinical, Radiographic, and Biochemical Characterization of Multiple Myeloma Patients with Osteonecrosis of the Jaw

enthalten in: Clinical cancer research | 2008

von Raje, N. | Woo, S. | Hande, K. | +16

110

p38 mitogen-activated protein kinase inhibitor LY2228820 enhances bortezomib-induced cytotoxicity and inhibits osteoclastogenesis in multiple myeloma; therapeutic implications

enthalten in: British journal of haematology | 2008

von Ishitsuka, K. | Hideshima, T. | Neri, P. | +16